Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
17th December 2020 | Randal J Kirk | 1,704 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 70,092 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 18,482 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 18,482 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 199,682 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 303 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 30 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 1,848 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 303 | Other acquisition or disposition | $0.00 | |
17th December 2020 | Randal J Kirk | 3,637 | Other acquisition or disposition | $0.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.
Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.